Schmidt 2017.
Study characteristics | ||
Methods | Before and after evaluation cohort to evaluate impact of roll‐out of Xpert MTB/RIF on detection and treatment of adults with pulmonary tuberculosis | |
Participants | 18 years old and above Adults suspected of pulmonary tuberculosis Female: 45.9% before, 44.1% after HIV infection was not reported Setting: primary health care in the Cape Winelands East in Weastern Cape. The Cape Winelands is a semi‐rural area with a very high estimated total tuberculosis case notification rate of 1400 per 100,000 population Country: South Africa Sample size: 15,629 before; 10,741 after |
|
Interventions | Data were collected from the electronic NHLS database, which records all microbiological tests for tuberculosis in the region, including the type of test (sputum smear microscopy, Xpert MTB/RIF, or liquid culture), and the result of each test. Unique individuals tested for pulmonary tuberculosis were identified by unique laboratory identifiers. Data from the two periods were compared for the proportion of participants investigated for tuberculosis who tested positive by sputum smear microscopy, liquid culture, or Xpert MTB/RIF, and the proportion of sputum smear microscopy, liquid culture, or Xpert MRB/RIF tests that were positive. | |
Outcomes |
Primary outcome: tuberculosis detection Secondary outcome:
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | A before‐after study, no randomization was done |
Allocation concealment (selection bias) | High risk | A before‐after study, where allocation of intervention was not concealed; allocation was determined by calender period |
Baseline characteristics similar (selection bias) | Low risk | No substantial differences observed |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No blinding was done |
Protection against contamination (performance bias) | Low risk | Data were extracted by specific test used, based on the unique laboratory identifier |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Data were available prior to the evaluation; outcome assessor unlikely to be blinded in routine care |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Missing data were similar before and after intervention, and not statistically different |
Selective reporting (reporting bias) | Low risk | All outcomes stated in the methods were reported |
Other bias | High risk | Risk of confounding due to before‐after design |